{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:04:42Z","timestamp":1794038682929,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Seed Grant"],"award-info":[{"award-number":["Seed Grant"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001771","name":"University of Newcastle Australia","doi-asserted-by":"publisher","award":["Postgraduate Research Scholarship"],"award-info":[{"award-number":["Postgraduate Research Scholarship"]}],"id":[{"id":"10.13039\/501100001771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anxiety and depression are comorbidities of severe asthma. However, clinical characteristics associated with coexisting severe asthma and anxiety\/depression are poorly understood. The study objective is to determine clinical characteristics associated with anxiety and depressive symptoms in severe asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Severe asthma participants (N\u2009=\u2009140) underwent a multidimensional assessment. Categorization of symptoms of anxiety and depression were based on HADS scale sub-scores and divided into four groups (&lt;\u20098 on both subscales;\u2009\u2265\u20098 on one subscale;\u2009\u2265\u20098 on both subscales). Clinical characteristics were compared between subgroups. Multivariate logistic regression determined associations of clinical characteristics and anxiety and\/or depressive symptoms in people with severe asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants were (mean\u2009\u00b1\u2009SD) 59.3\u2009\u00b1\u200914.7\u00a0years old, and 62% female. There were 74 (53%) severe asthma participants without symptoms of anxiety\/depression, 11 (7%) with symptoms of anxiety, 37 (26%) with symptoms of depression and 18 (13%) with symptoms of anxiety and depression. Quality of life impairment was greater in participants with symptoms of depression (4.4\u2009\u00b1\u20091.2) and combined symptoms of anxiety and depression (4.4\u2009\u00b1\u20091.1). Asthma control was worse in those with symptoms of depression (2.9\u2009\u00b1\u20091.1) and combined anxiety and depression (2.6\u2009\u00b1\u20091.0). In multivariate models, dysfunctional breathing was associated with symptoms of anxiety (OR\u2009=\u20091.24 [1.01, 1.53]). Dyspnoea was associated with symptoms of depression (OR\u2009=\u20091.90 [1.10, 3.25]). Dysfunctional breathing (OR 1.16 [1.04, 1.23]) and obesity (OR 1.17 [1.00, 1.35]) were associated with combined symptoms of anxiety and depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>People with severe asthma and anxiety and\/or depressive symptoms have poorer QoL and asthma control. Dyspnoea, dysfunctional breathing and obesity are associated with these symptoms. These key clinical characteristics should be targeted in severe asthma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-02266-5","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T05:02:46Z","timestamp":1670821366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma"],"prefix":"10.1186","volume":"23","author":[{"given":"Michelle A.","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Yorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"2266_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343.","journal-title":"Eur Respir J"},{"issue":"6","key":"2266_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","volume":"2","author":"A von Bulow","year":"2014","unstructured":"von Bulow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759\u201367.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2266_CR3","doi-asserted-by":"crossref","unstructured":"McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J. Health-related quality of life burden in severe asthma. MJA. 2018:S28\u2013S33.","DOI":"10.5694\/mja18.00207"},{"key":"2266_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JAA.S150462","volume":"10","author":"L Brussino","year":"2017","unstructured":"Brussino L, Solidoro P, Rolla G. Is it severe asthma or asthma with severe comorbidities? J Asthma Allergy. 2017;10:303\u20135.","journal-title":"J Asthma Allergy"},{"issue":"1","key":"2266_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/resp.13389","volume":"24","author":"VM McDonald","year":"2019","unstructured":"McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, et al. Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology (Carlton, Vic). 2019;24(1):37\u201347.","journal-title":"Respirology (Carlton, Vic)"},{"issue":"Suppl 3","key":"2266_CR6","first-page":"A193","volume":"72","author":"J Finnerty","year":"2017","unstructured":"Finnerty J, Paszek G, Sehgal N. P204 Prevalence of anxiety and depression in patients with severe asthma. Thorax. 2017;72(Suppl 3):A193.","journal-title":"Thorax"},{"issue":"5","key":"2266_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1183\/09031936.05.00037905","volume":"26","author":"A ten Brinke","year":"2005","unstructured":"ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26(5):812\u20138.","journal-title":"Eur Respir J"},{"issue":"1","key":"2266_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12916-020-01738-z","volume":"18","author":"RN Groen","year":"2020","unstructured":"Groen RN, Ryan O, Wigman JTW, Riese H, Penninx B, Giltay EJ, et al. Comorbidity between depression and anxiety: assessing the role of bridge mental states in dynamic psychological networks. BMC Med. 2020;18(1):308.","journal-title":"BMC Med"},{"issue":"11","key":"2266_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1037\/bul0000111","volume":"143","author":"NC Jacobson","year":"2017","unstructured":"Jacobson NC, Newman MG. Anxiety and depression as bidirectional risk factors for one another: a meta-analysis of longitudinal studies. Psychol Bull. 2017;143(11):1155\u2013200.","journal-title":"Psychol Bull"},{"issue":"4","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5694\/mjao12.10628","volume":"1","author":"JWG Tiller","year":"2012","unstructured":"Tiller JWG. Depression and anxiety. Med J Aust. 2012;1(4):28\u201331.","journal-title":"Med J Aust"},{"issue":"1","key":"2266_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026485530405","volume":"25","author":"JB Nitschke","year":"2001","unstructured":"Nitschke JB, Heller W, Imig JC, McDonald RP, Miller GA. Distinguishing dimensions of anxiety and depression. Cogn Ther Res. 2001;25(1):1\u201322.","journal-title":"Cogn Ther Res"},{"issue":"7","key":"2266_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/02699931.2017.1330255","volume":"32","author":"MW Eysenck","year":"2018","unstructured":"Eysenck MW, Fajkowska M. Anxiety and depression: toward overlapping and distinctive features. Cogn Emot. 2018;32(7):1391\u2013400.","journal-title":"Cogn Emot"},{"issue":"3","key":"2266_CR13","doi-asserted-by":"publisher","first-page":"1901509","DOI":"10.1183\/13993003.01509-2019","volume":"55","author":"VM McDonald","year":"2020","unstructured":"McDonald VM, Clark VL, Cordova-Rivera L, Wark PAB, Baines KJ, Gibson PG. Targeting treatable traits in severe asthma: a randomised controlled trial. Eur Respir J. 2020;55(3):1901509.","journal-title":"Eur Respir J"},{"issue":"9743","key":"2266_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(10)61087-2","volume":"376","author":"PG Gibson","year":"2010","unstructured":"Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet. 2010;376(9743):803\u201313.","journal-title":"Lancet"},{"issue":"4","key":"2266_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, O\u2019Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902\u20137.","journal-title":"Eur Respir J"},{"issue":"2","key":"2266_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"5","key":"2266_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","volume":"184","author":"RA Dweik","year":"2011","unstructured":"Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (Fe(NO)) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602\u201315.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2266_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0022-3999(85)90042-X","volume":"29","author":"J Van Dixhoorn","year":"1985","unstructured":"Van Dixhoorn J, Duivenvoorden H. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985;29(2):199\u2013206.","journal-title":"J Psychosom Res"},{"issue":"6","key":"2266_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428\u201346.","journal-title":"Eur Respir J"},{"issue":"6","key":"2266_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"2266_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","volume":"115","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115(5):1265\u201370.","journal-title":"Chest"},{"issue":"1","key":"2266_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-019-3800-y","volume":"21","author":"R Sohanpal","year":"2020","unstructured":"Sohanpal R, Pinnock H, Steed L, Marshall KH, Chan C, Kelly M, et al. Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial. Trials. 2020;21(1):1\u201312.","journal-title":"Trials"},{"issue":"133","key":"2266_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1183\/09059180.00007813","volume":"23","author":"AM Yohannes","year":"2014","unstructured":"Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345\u20139.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"2266_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1590\/S1516-44462006005000005","volume":"28","author":"AM Valenca","year":"2006","unstructured":"Valenca AM, Falcao R, Freire RC, Nascimento I, Nascentes R, Zin WA, et al. The relationship between the severity of asthma and comorbidities with anxiety and depressive disorders. Rev Bras Psiquiatr. 2006;28(3):206\u20138.","journal-title":"Rev Bras Psiquiatr"},{"key":"2266_CR25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1378\/chest.97.3.628","volume":"97","author":"P Yellowlees","year":"1990","unstructured":"Yellowlees P, Kalucy R. Psychobiological aspects of asthma and the consequent research implications. Chest. 1990;97:628\u201334.","journal-title":"Chest"},{"issue":"6 Suppl","key":"2266_CR26","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1067\/mai.2002.129966","volume":"110","author":"MR Sears","year":"2002","unstructured":"Sears MR. Adverse effects of beta-agonists. J Allergy Clin Immunol. 2002;110(6 Suppl):S322\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2266_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4088\/PCC.v02n0501","volume":"2","author":"TA Zielinski","year":"2000","unstructured":"Zielinski TA, Brown ES, Nejtek VA, Khan DA, Moore JJ, Rush AJ. Depression in asthma: prevalence and clinical implications. Prim Care Companion J Clin Psychiatry. 2000;2(5):153\u20138.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"11","key":"2266_CR28","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.rmed.2014.09.007","volume":"108","author":"M Leander","year":"2014","unstructured":"Leander M, Lampa E, Rask-Andersen A, Franklin K, Gislason T, Oudin A, et al. Impact of anxiety and depression on respiratory symptoms. Respir Med. 2014;108(11):1594\u2013600.","journal-title":"Respir Med"},{"issue":"4","key":"2266_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1164\/ajrccm.149.4.8143058","volume":"149","author":"C Janson","year":"1994","unstructured":"Janson C, Bj\u00f6rnsson E, Hetta J, Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med. 1994;149(4):930\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2266_CR30","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.rmed.2006.01.016","volume":"100","author":"\u00c5 Neuman","year":"2006","unstructured":"Neuman \u00c5, Gunnbj\u00f6rnsdottir M, Tuns\u00e4ter A, Nystr\u00f6m L, Franklin KA, Norrman E, et al. Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Med. 2006;100(10):1843\u20139.","journal-title":"Respir Med"},{"issue":"1","key":"2266_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.24869\/psyd.2018.11","volume":"30","author":"L Basara","year":"2018","unstructured":"Basara L, Jokic Begic N, Popovic Grle S, Jakopovic M, SamarZija M. Dyspnea from neuropsychyatric perspective: a narrative review. Psychiatr Danub. 2018;30(1):11\u201320.","journal-title":"Psychiatr Danub"},{"issue":"4","key":"2266_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/bja\/aer040","volume":"106","author":"T Nishino","year":"2011","unstructured":"Nishino T. Dyspnoea: underlying mechanisms and treatment. BJA Br J Anaesthesia. 2011;106(4):463\u201374.","journal-title":"BJA Br J Anaesthesia."},{"issue":"6","key":"2266_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1081\/JAS-100105865","volume":"38","author":"HL Manning","year":"2001","unstructured":"Manning HL, Schwartzstein RM. Respiratory sensations in asthma: physiological and clinical implications. J Asthma. 2001;38(6):447\u201360.","journal-title":"J Asthma"},{"issue":"1","key":"2266_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2013.06.005","volume":"76","author":"A Hayen","year":"2013","unstructured":"Hayen A, Herigstad M, Pattinson KT. Understanding dyspnea as a complex individual experience. Maturitas. 2013;76(1):45\u201350.","journal-title":"Maturitas"},{"issue":"1","key":"2266_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1741-7015-11-200","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk M, Williams LJ, Jacka FN, O\u2019Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11(1):200.","journal-title":"BMC Med"},{"issue":"4","key":"2266_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.paid.2008.11.006","volume":"46","author":"S Petersen","year":"2009","unstructured":"Petersen S, Ritz T. The association of respiratory sensations with depressive mood is distinct from the association with anxious mood. Personality Individ Differ. 2009;46(4):406\u201311.","journal-title":"Personality Individ Differ"},{"key":"2266_CR37","doi-asserted-by":"crossref","unstructured":"Miller GE, Freedland KE, Carney RM. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003;17.","DOI":"10.1016\/S0889-1591(03)00057-6"},{"issue":"1","key":"2266_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137\u201362.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2266_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-7022-2-18","volume":"2","author":"I Agache","year":"2012","unstructured":"Agache I, Ciobanu C, Paul G, Rogozea L. Dysfunctional breathing phenotype in adults with asthma-incidence and risk factors. Clin Transl Allergy. 2012;2(1):1\u20137.","journal-title":"Clin Transl Allergy"},{"key":"2266_CR40","doi-asserted-by":"crossref","unstructured":"Stevenson IAN, Ripley HS. Variations in respiration and in respiratory symptoms during changes in emotion. Psychosom Med. 1952;14(6).","DOI":"10.1097\/00006842-195211000-00006"},{"key":"2266_CR41","doi-asserted-by":"crossref","unstructured":"Denton E, Bondarenko J, Tay T, Lee J, Radhakrishna N, Hore-Lacy F, et al. Factors associated with dysfunctional breathing in patients with difficult to treat asthma. J Allergy Clin Immunol. 2018.","DOI":"10.1016\/j.jaip.2018.11.037"},{"issue":"141","key":"2266_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1183\/16000617.0088-2015","volume":"25","author":"R Boulding","year":"2016","unstructured":"Boulding R, Stacey R, Niven R, Fowler SJ. Dysfunctional breathing: a review of the literature and proposal for classification. Eur Respir. 2016;25(141):287\u201394.","journal-title":"Eur Respir"},{"issue":"6","key":"2266_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/cea.13153","volume":"48","author":"SA Hiles","year":"2018","unstructured":"Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, et al. Working while unwell: workplace impairment in people with severe asthma. Clin Exp Allergy. 2018;48(6):650\u201362.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"2266_CR44","first-page":"814","volume":"6","author":"L Cordova-Rivera","year":"2018","unstructured":"Cordova-Rivera L, Gibson PG, Gardiner PA, Powell H, McDonald VM. Physical activity and exercise capacity in severe asthma: key clinical associations. J Allergy Clin Immunol. 2018;6(3):814\u201322.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2266_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.psychres.2009.04.015","volume":"178","author":"L De Wit","year":"2010","unstructured":"De Wit L, Luppino F, van Straten A, Penninx B, Zitman F, Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230\u20135.","journal-title":"Psychiatry Res"},{"issue":"1\u20133","key":"2266_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jad.2009.02.001","volume":"118","author":"LJ Williams","year":"2009","unstructured":"Williams LJ, Pasco JA, Henry MJ, Jacka FN, Dodd S, Nicholson GC, et al. Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord. 2009;118(1\u20133):173\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"2266_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s40211-019-0302-9","volume":"33","author":"S Amiri","year":"2019","unstructured":"Amiri S, Behnezhad S. Obesity and anxiety symptoms: a\u00a0systematic review and meta-analysis. Neuropsychiatrie. 2019;33(2):72\u201389.","journal-title":"Neuropsychiatrie"},{"issue":"2","key":"2266_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1037\/a0025536","volume":"31","author":"J-P Gouin","year":"2012","unstructured":"Gouin J-P, Glaser R, Malarkey WB, Beversdorf D, Kiecolt-Glaser J. Chronic stress, daily stressors, and circulating inflammatory markers. Health Psychol. 2012;31(2):264.","journal-title":"Health Psychol"},{"issue":"4","key":"2266_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/cyto.1997.0290","volume":"10","author":"M Maes","year":"1998","unstructured":"Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety. Cytokine. 1998;10(4):313\u20138.","journal-title":"Cytokine"},{"issue":"7","key":"2266_CR50","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1081\/JAS-120023497","volume":"40","author":"ES Ford","year":"2003","unstructured":"Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma. 2003;40(7):733\u20139.","journal-title":"J Asthma"},{"issue":"6","key":"2266_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448\u201354.","journal-title":"N Engl J Med"},{"issue":"5","key":"2266_CR52","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2005.01.064","volume":"115","author":"SA Shore","year":"2005","unstructured":"Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol. 2005;115(5):925\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"2266_CR53","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.domaniend.2016.03.004","volume":"56","author":"SD Hewagalamulage","year":"2016","unstructured":"Hewagalamulage SD, Lee T, Clarke I, Henry B. Stress, cortisol, and obesity: a role for cortisol responsiveness in identifying individuals prone to obesity. Domest Anim Endocrinol. 2016;56:S112\u201320.","journal-title":"Domest Anim Endocrinol"},{"issue":"4","key":"2266_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1467-789X.2001.00040.x","volume":"2","author":"RL Kolotkin","year":"2001","unstructured":"Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev. 2001;2(4):219\u201329.","journal-title":"Obes Rev"},{"key":"2266_CR55","unstructured":"Sastre J, Crespo A, Fernandez-Sanchez A, Rial M, Plaza V, Gonz\u00e1lez FC, et al. Anxiety, depression, and asthma control: changes after standardized treatment. J Allergy Clin Immunol. 2018."},{"issue":"2","key":"2266_CR56","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1183\/20734735.0165-2019","volume":"15","author":"MA Stubbs","year":"2019","unstructured":"Stubbs MA, Clark VL, McDonald VM. Living well with severe asthma. Breathe. 2019;15(2):e40\u20139.","journal-title":"Breathe"},{"issue":"2","key":"2266_CR57","first-page":"S28","volume":"209","author":"V McDonald","year":"2018","unstructured":"McDonald V, Hiles S, Jones K, Clark V, Yorke J. Health-related quality of life burden in severe asthma. Med J Aust. 2018;209(2):S28\u201333.","journal-title":"Med J Aust"},{"issue":"3","key":"2266_CR58","doi-asserted-by":"publisher","first-page":"1700765","DOI":"10.1183\/13993003.00765-2017","volume":"50","author":"JM Foster","year":"2017","unstructured":"Foster JM, McDonald VM, Guo M, Reddel Helen K. \u201cI have lost in every facet of my life\u201d: the hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765.","journal-title":"Eur Respir J"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02266-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T08:04:08Z","timestamp":1670832248000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02266-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02266-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted from Hunter New England Local Health District Human Research Ethics Committee (08\/08\/20\/3.10). The study was conducted in accordance with Good Clinical Practice Guidelines and ethical principles consistent with the Declaration of Helsinki. All participants provided written informed consent, with investigators obtaining signed and dated consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.A. Stubbs reports personal speaker fees from AstraZeneca, outside the submitted work. V.L. Clark receives a fellowship from the National Health and Medical Research Council, Centre of Research Excellence in Severe Asthma, and also reports a grant from AstraZeneca to cover research-related costs, received for providing education to AstraZeneca staff, outside the submitted work. J. Yorke reports personal fees from Dysnpoae-12 questionnaire, personal fees from SGRQ-I questionnaire, outside the submitted work. P.G. Gibson reports personal fees from AstraZeneca, GlaxoSmithKline, Novartis, Grants from AstraZeneca, GlaxoSmithKline, outside the submitted work. V.M. McDonald reports grants and speaker fees from GlaxoSmithKline and AstraZeneca, and advisory board fees from Novartis, all outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}